
1001 - 5000 employees
Founded 1991
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Sobi - Swedish Orphan Biovitrum AB (publ) is a global leader in providing innovative treatments for people with rare diseases. Specializing in therapeutic areas such as haematology and immunology, Sobi is committed to improving patient access to medicines for rare and debilitating conditions. With a strong R&D pipeline, the company is actively pursuing new therapies and collaborating globally to transform patient care in areas such as haemophilia and immune thrombocytopenia. Sobi also engages in extensive sustainability and humanitarian aid programs, demonstrating a firm commitment to patient-centric care and societal contributions.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🔥 1 hour ago
Senior Medical Science Liaison advancing Sobi’s rare-disease lymphoma therapy, lacutamab. Building scientific partnerships and supporting CTCL strategy, launch readiness, and evidence generation.
🔥 1 hour ago
Senior Medical Science Liaison advancing Sobi’s rare-disease lymphoma therapy lacutamab. Building scientific relationships and supporting U.S. medical strategy, launch readiness, and evidence generation.
🔥 1 hour ago
Senior Medical Science Liaison advancing Sobi’s rare-disease lymphoma therapy, lacutamab. Building scientific relationships, generating insights, and supporting US launch readiness.
🔥 1 hour ago
Senior Medical Science Liaison advancing Sobi’s rare-disease lymphoma therapy lacutamab. Building scientific relationships, supporting launch readiness, and generating CTCL medical insights.
🔥 1 hour ago
Senior Medical Science Liaison advancing Sobi’s rare-disease lymphoma therapy, lacutamab. Building CTCL scientific partnerships, insights, and launch readiness across the continental U.S.
🔥 1 hour ago
Senior Medical Science Liaison advancing Sobi’s rare-disease lymphoma therapy, lacutamab. Building CTCL scientific partnerships and supporting US launch readiness.
🔥 1 hour ago
Senior Medical Science Liaison advancing Sobi’s rare-disease lymphoma therapy, lacutamab. Building scientific relationships and supporting CTCL strategy, launch readiness, and evidence generation.
🔥 1 hour ago
Senior Medical Science Liaison advancing Sobi’s rare-disease lymphoma therapy, lacutamab. Building scientific relationships and supporting US CTCL strategy, launch readiness, and evidence generation.
🔥 1 hour ago
Senior Medical Science Liaison advancing Sobi’s rare-disease lymphoma therapy lacutamab across the continental U.S. Building scientific partnerships, generating insights, and supporting launch readiness.
🔥 1 hour ago
Senior Medical Science Liaison advancing Sobi’s lacutamab therapy for cutaneous T-cell lymphoma. Building scientific partnerships, generating insights, and supporting U.S. launch readiness.
🕒 2 days ago
Senior MSL advancing Sobi’s rare-disease lymphoma therapies and lacutamab launch readiness. Building scientific relationships and generating CTCL insights across the continental U.S.
🕒 2 days ago
Senior Medical Science Liaison advancing Sobi’s rare-disease lymphoma therapy, lacutamab, across U.S. territories. Building scientific relationships, supporting launch readiness, and generating CTCL medical insights.
🕒 2 days ago
Senior Medical Science Liaison advancing Sobi’s lacutamab therapy for CTCL and lymphoma. Building scientific partnerships and supporting US medical strategy, launch readiness, and evidence generation.
🕒 2 days ago
Senior MSL advancing Sobi’s rare-disease lymphoma therapy lacutamab across U.S. medical communities. Building scientific relationships, generating insights, and supporting launch readiness.
🕒 2 days ago
Senior Medical Science Liaison advancing Sobi’s rare-disease lymphoma therapy, lacutamab. Building CTCL scientific partnerships and supporting U.S. medical strategy, launch readiness, and evidence generation.
🕒 2 days ago
Senior Medical Science Liaison advancing Sobi’s lacutamab therapy for cutaneous T-cell lymphoma. Building scientific partnerships and supporting US launch readiness, evidence generation, and medical strategy.
🕒 2 days ago
Senior MSL advancing Sobi’s rare-disease lymphoma therapy lacutamab across the continental U.S. Building scientific relationships, generating insights, and supporting launch readiness.
🕒 2 days ago
Senior MSL guiding CTCL scientific engagement and lacutamab launch readiness for Sobi, a rare-disease biopharmaceutical company. Generating insights and supporting hematology-oncology clinical development across the continental U.S.
🕒 2 days ago
Senior Medical Science Liaison advancing Sobi’s lacutamab lymphoma immunotherapy. Building scientific relationships, generating insights, and supporting launch readiness across the continental U.S.
🕒 2 days ago
Senior Medical Science Liaison advancing Sobi’s lacutamab lymphoma immunotherapy. Building scientific relationships and supporting CTCL strategy, launch readiness, and clinical development.
+46 More Jobs Available!
We scan the internet everyday and find jobs not posted on LinkedIn or other job boards.
We find jobs minutes after they're posted, so you can apply before everyone else.
Most members hear back within the first week
We find jobs other job boards miss.